Physician profile
Gary H Emerson
NPI 1770556169
$4,102.73
in general payments reported to CMS, 2019-2025
47 companies · $672 in 2025
The $672 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $214 · 2021: $705 · 2022: $773 · 2023: $666 · 2024: $634 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,787 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,786.87 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $869.31 | 2019-2024 | |
| Astellas Pharma US INC | $311.28 | 2019-2025 | Veozah, Myrbetriq |
| Sage Therapeutics, LLC | $237.22 | 2024-2025 | Zurzuvae |
| Organon LLC | $209.87 | 2021-2024 | Nexplanon |
| Daiichi Sankyo INC. | $191.00 | 2019-2024 | Injectafer |
| Aspira Women'S Health INC | $176.65 | 2021-2024 | Ova1 |
| Hologic Sales and Service, LLC | $171.60 | 2023-2025 | Thinprep 2000 Processor, Aptima, Fluent Fluid Management System |
| Bayer Healthcare Pharmaceuticals INC. | $133.55 | 2019-2025 | |
| Avion Pharmaceuticals | $117.38 | 2019-2021 | |
| Scynexis, INC. | $104.01 | 2022 | |
| Exeltis, USA INC. | $103.10 | 2021-2025 | Slynd |
| Pfizer INC. | $95.44 | 2019-2025 | |
| Therapeuticsmd, INC. | $93.97 | 2019-2022 | |
| Meditrina | $92.60 | 2023-2024 | |
| Intuitive Surgical, INC. | $90.00 | 2024-2025 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Emerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.